{"filing":{"accession_number":"0001171843-26-003877","cik":"0001123494","ticker":"HBIO","company_name":"HARVARD BIOSCIENCE INC","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"f8k_060226.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/f8k_060226.htm"},"events":[{"id":2747,"run_id":2387,"accession_number":"0001171843-26-003877","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Harvard Bioscience held its Annual Meeting on June 2, 2026, with shareholders voting on five proposals: election of directors, auditor ratification, executive compensation advisory vote, ESPP plan amendment, and incentive plan amendment.","company_name":"HARVARD BIOSCIENCE INC","ticker":"HBIO","filing_date":"2026-06-02","items":[{"id":3515,"accession_number":"0001171843-26-003877","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Harvard Bioscience's Annual Meeting held on June 2, 2026, covering five proposals: election of directors, auditor ratification, executive compensation advisory vote, ESPP plan amendment, and incentive plan amendment. Item 5.07 explicitly requires disclosure of shareholder vote results, and these outcomes are material to investors assessing board composition, auditor independence, and equity plan authorization.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:05.230943+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":2748,"run_id":2387,"accession_number":"0001171843-26-003877","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Shareholders approved amendments to the Amended and Restated 2021 Incentive Plan (increasing authorized shares by 400,000 for future awards) and an amendment to the Employee Stock Purchase Plan, materially affecting the equity compensation pool and potential dilution.","company_name":"HARVARD BIOSCIENCE INC","ticker":"HBIO","filing_date":"2026-06-02","items":[{"id":3514,"accession_number":"0001171843-26-003877","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of amendments to two executive compensation plans: the Amended and Restated 2021 Incentive Plan (increasing authorized shares by 400,000 for future awards) and an amendment to the Employee Stock Purchase Plan. These are compensatory arrangements for officers and employees, directly falling under Item 5.02(e) and the exec_compensation category. The increase in share authorization is material as it affects the pool available for equity compensation and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:05.230943+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3514,"accession_number":"0001171843-26-003877","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of amendments to two executive compensation plans: the Amended and Restated 2021 Incentive Plan (increasing authorized shares by 400,000 for future awards) and an amendment to the Employee Stock Purchase Plan. These are compensatory arrangements for officers and employees, directly falling under Item 5.02(e) and the exec_compensation category. The increase in share authorization is material as it affects the pool available for equity compensation and potential dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:05.230943+00:00","company_name":"HARVARD BIOSCIENCE INC","ticker":"HBIO","filing_date":"2026-06-02"},{"id":3515,"accession_number":"0001171843-26-003877","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Harvard Bioscience's Annual Meeting held on June 2, 2026, covering five proposals: election of directors, auditor ratification, executive compensation advisory vote, ESPP plan amendment, and incentive plan amendment. Item 5.07 explicitly requires disclosure of shareholder vote results, and these outcomes are material to investors assessing board composition, auditor independence, and equity plan authorization.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:13:05.230943+00:00","company_name":"HARVARD BIOSCIENCE INC","ticker":"HBIO","filing_date":"2026-06-02"}]}